Global Information
회사소개 | 문의 | 비교리스트

세계의 척수 외상 치료 시장

Spinal Cord Trauma Treatment

리서치사 Global Industry Analysts, Inc.
발행일 2021년 04월 상품코드 958714
페이지 정보 영문 218 Pages 배송안내 1-2일 (영업일 기준)
가격
US $ 4,950 ₩ 6,444,000 PDF (Single User License)
US $ 14,850 ₩ 19,334,000 PDF (Global License to Company and its Fully-owned Subsidiaries)


세계의 척수 외상 치료 시장 Spinal Cord Trauma Treatment
발행일 : 2021년 04월 페이지 정보 : 영문 218 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 척수 외상 치료 시장 규모는 분석기간(2020년-2027년)에 3.5%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 23억 달러에서 2027년에는 29억 달러에 달할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 코르티코스테로이드는 분석기간 중 3.4%의 CAGR을 나타내고, 9억 9,930만 달러에 달할 전망입니다.

세계의 척수 외상 치료(Spinal Cord Trauma Treatment) 시장에 대해 조사했으며, 시장 점유율, 동향 및 전망, 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 사례

  • Acorda Therapeutics, Inc.
  • Asterias Biotherapeutics, Inc.
  • BioArctic AB
  • Bioaxone Biosciences Inc.
  • BioTime, Inc.
  • InVivo Therapeutics Holdings Corporation
  • Kringle Pharma Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Pharmicell Co., Ltd.
  • ReNetX Bio
  • Vertex Pharmaceuticals Inc.

목차

I. 서론, 조사 방법, 조사 범위

II. 주요 요약

  • 시장 개요
    • 경쟁사의 시장 점유율
    • 경쟁사의 시장 점유율 시나리오
    • Covid-19의 영향과 다가오는 세계의 경기후퇴
  • 주요 기업
  • 동향과 성장 촉진요인
  • 세계 시장 전망

III. 시장 분석

  • 지역별 시장 분석
  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

IV. 경쟁

  • 기업 개요 : 41개사
KSM 20.10.05

Abstract:

Global Spinal Cord Trauma Treatment Market to Reach $2.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Spinal Cord Trauma Treatment estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 3.5% over the analysis period 2020-2027. Corticosteroid, one of the segments analyzed in the report, is projected to record a 3.4% CAGR and reach US$999.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Surgery segment is readjusted to a revised 4.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $679.7 Million, While China is Forecast to Grow at 3.3% CAGR

The Spinal Cord Trauma Treatment market in the U.S. is estimated at US$679.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$524 Million by the year 2027 trailing a CAGR of 3.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Spinal Traction Segment to Record 2.7% CAGR

In the global Spinal Traction segment, USA, Canada, Japan, China and Europe will drive the 2.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$491.7 Million in the year 2020 will reach a projected size of US$598.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$327.7 Million by the year 2027.

Select Competitors (Total 41 Featured) -

  • Acorda Therapeutics, Inc.
  • Asterias Biotherapeutics, Inc.
  • BioArctic AB
  • Bioaxone Biosciences Inc.
  • BioTime, Inc.
  • InVivo Therapeutics Holdings Corporation
  • Kringle Pharma Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Pharmicell Co., Ltd.
  • ReNetX Bio
  • Vertex Pharmaceuticals Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Spinal Cord Trauma Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Spinal Cord Trauma Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Spinal Cord Trauma Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Corticosteroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Corticosteroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Corticosteroid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Spinal Traction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Spinal Traction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Spinal Traction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Complete Spinal Cord Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Complete Spinal Cord Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Complete Spinal Cord Injuries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Partial Spinal Cord Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Partial Spinal Cord Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Partial Spinal Cord Injuries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Trauma Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Trauma Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Trauma Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 34: Canada Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 37: Canada Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 43: Japan Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Japan 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 46: Japan Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Japan Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Japan 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 49: Japan Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Japan 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 52: China Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: China Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: China 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 55: China Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: China Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: China 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 58: China Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: China Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: China 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 61: Europe Current & Future Analysis for Spinal Cord Trauma Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 62: Europe Historic Review for Spinal Cord Trauma Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: Europe 15-Year Perspective for Spinal Cord Trauma Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 64: Europe Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Europe Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Europe 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Europe 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 73: France Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: France Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: France 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 76: France Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: France Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: France 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 79: France Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: France 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 82: Germany Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Germany Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Germany 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 85: Germany Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Germany Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Germany 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 88: Germany Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Germany Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Germany 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 91: Italy Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Italy Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Italy 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 94: Italy Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Italy Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Italy 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 97: Italy Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Italy 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 100: UK Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: UK Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: UK 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 103: UK Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: UK Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: UK 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 106: UK Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UK Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: UK 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 109: Rest of Europe Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Rest of Europe Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: Rest of Europe 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 112: Rest of Europe Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Rest of Europe Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: Rest of Europe 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 115: Rest of Europe Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Rest of Europe Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 117: Rest of Europe 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 118: Asia-Pacific Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Asia-Pacific Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 120: Asia-Pacific 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 121: Asia-Pacific Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Asia-Pacific Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 123: Asia-Pacific 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 124: Asia-Pacific Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Asia-Pacific Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 126: Asia-Pacific 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 127: Rest of World Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Rest of World Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Corticosteroid, Surgery and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 129: Rest of World 15-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroid, Surgery and Spinal Traction for the Years 2012, 2020 & 2027
    • TABLE 130: Rest of World Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of World Historic Review for Spinal Cord Trauma Treatment by Injury Type - Complete Spinal Cord Injuries and Partial Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of World 15-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injuries and Partial Spinal Cord Injuries for the Years 2012, 2020 & 2027
    • TABLE 133: Rest of World Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of World Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of World 15-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 41
Back to Top
전화 문의
F A Q